Equity Create Wealth
Sectoral Fund - Pharma & Health Care
Category Rank
Iti Pharma And Healthcare Fund - Regular Plan - Idcw Reinvestment
Rating
Fund
Time to Invest
Iti Pharma And Healthcare Fund - Regular Plan - Idcw Reinvestment
NAV
10.8007
(25/09/2023)
L 52Wk H
8.72
11.19
Login using to know what your Friends are Investing !

Iti Pharma And Healthcare Fund - Regular Plan - Idcw Reinvestment

Equity
Sectoral Fund - Pharma & Health Care
Create Wealth
Rank Iti Pharma And Healthcare Fund - Regular Plan - Idcw Reinvestment
Fund
NAV
10.8007
(25/09/2023)
Time to Invest
Iti Pharma And Healthcare Fund - Regular Plan - Idcw Reinvestment
Rating
L 52Wk H
8.72
11.19

Asset Allocation for Iti Pharma And Healthcare Fund - Regular Plan - Idcw Reinvestment Fund Growth

Top 10 Holdings of Iti Pharma And Healthcare Fund - Regular Plan - Idcw Reinvestment Fund Growth

58.86 % of total assets
Sun Pharmaceutical Industries LimitedSun Pharmaceutical Industries Limited(15.94%)
Cipla LimitedCipla Limited(7.31%)
Dr. Reddy's Laboratories LimitedDr. Reddy's Laboratories Limited(5.70%)
Max Healthcare Institute LimitedMax Healthcare Institute Limited(5.51%)
Lupin LimitedLupin Limited(5.30%)
Torrent Pharmaceuticals LimitedTorrent Pharmaceuticals Limited(4.45%)
Suven Pharmaceuticals LimitedSuven Pharmaceuticals Limited(4.17%)
Apollo Hospitals Enterprise LimitedApollo Hospitals Enterprise Limited(3.59%)
Alkem Laboratories LimitedAlkem Laboratories Limited(3.51%)
Aurobindo Pharma LimitedAurobindo Pharma Limited(3.37%)

Detailed Portfolio of Iti Pharma And Healthcare Fund - Regular Plan - Idcw Reinvestment Fund Growth

Portfolio Date -31 Aug 2023
Equity Holdings -36
Other Holdings -1
Holdings % Weight Value Sahi Hai/Nahi
Sun Pharmaceutical Industries Limited 15.94% 21.987 Cr
Cipla Limited 7.31% 10.086 Cr
Dr. Reddy's Laboratories Limited 5.70% 7.870 Cr
Max Healthcare Institute Limited 5.51% 7.602 Cr
Lupin Limited 5.30% 7.316 Cr
Torrent Pharmaceuticals Limited 4.45% 6.138 Cr
Suven Pharmaceuticals Limited 4.17% 5.748 Cr
Apollo Hospitals Enterprise Limited 3.59% 4.958 Cr
Alkem Laboratories Limited 3.51% 4.847 Cr
Aurobindo Pharma Limited 3.37% 4.645 Cr
Laurus Labs Limited 3.25% 4.487 Cr
Mankind Pharma Limited 3.16% 4.357 Cr
Syngene International Limited 3.08% 4.251 Cr
Zydus Lifesciences Limited 2.98% 4.108 Cr
Divi's Laboratories Limited 2.89% 3.991 Cr
FDC Limited 2.17% 2.993 Cr
JB Chemicals & Pharmaceuticals Limited 2.06% 2.844 Cr
Natco Pharma Limited 1.61% 2.215 Cr
Vishnu Chemicals Limited 1.54% 2.128 Cr
Gland Pharma Limited 1.42% 1.953 Cr
Alembic Pharmaceuticals Limited 1.40% 1.934 Cr
Astec LifeSciences Limited 1.38% 1.908 Cr
Ajanta Pharma Limited 1.38% 1.904 Cr
Metropolis Healthcare Limited 1.09% 1.504 Cr
Healthcare Global Enterprises Limited 1.05% 1.452 Cr
Sanofi India Limited 1.01% 1.387 Cr
Rainbow Childrens Medicare Limited 0.98% 1.354 Cr
Abbott India Limited 0.98% 1.352 Cr
Sun Pharma Advanced Research Company Limited 0.93% 1.282 Cr
Ami Organics Limited 0.91% 1.249 Cr
Fortis Healthcare Limited 0.86% 1.192 Cr
Gujarat Fluorochemicals Limited 0.84% 1.160 Cr
Vijaya Diagnostic Centre Limited 0.83% 1.144 Cr
Sequent Scientific Limited 0.78% 1.077 Cr
Dr. Lal Path Labs Limited 0.72% 0.989 Cr
TTK Healthcare Limited 0.70% 0.965 Cr
Holdings % Weight Value Sahi Hai/Nahi
Net Receivables / (Payables) 1.15% 1.579 Cr -

Insight on the composition of the Iti Pharma And Healthcare Fund - Regular Plan - Idcw Reinvestment Fund Growth

Iti Pharma And Healthcare Fund - Regular Plan - Idcw Reinvestment

Style Box of the Iti Pharma And Healthcare Fund - Regular Plan - Idcw Reinvestment Fund Growth

Iti Pharma And Healthcare Fund - Regular Plan - Idcw Reinvestment

Portfolio Characteristics of the Iti Pharma And Healthcare Fund - Regular Plan - Idcw Reinvestment Fund Growth

Iti Pharma And Healthcare Fund - Regular Plan - Idcw Reinvestment